DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Kopp MV. et al.
Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma.
Clin Exp Allergy 2009;
39: 271-279
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.